Efficacy of second-generation cryoballoon ablation in paroxysmal and persistent atrial fibrillation patients

    loading  Checking for direct PDF access through Ovid


AimsIn this study, we aimed to compare the efficacy of single pulmonary vein isolation with the second-generation cryoballoon (CB-Adv) and predictors of atrial fibrillation recurrences in patients with paroxysmal (PAF) and persistent atrial fibrillation (PersAF).MethodsConsecutive PAF and PersAF patients undergoing CB-Adv for the first time were enrolled. Patients were followed with in-clinic visits including Holter ECG. Atrial arrhythmic episodes symptomatic or documented lasting more than 30 s were considered as recurrences.ResultsA total of 96 consecutive patients [77 men (80%), mean age 57.4 ± 9.9 years] were included in this analysis. About 56 (58%) patients had PAF and 40 had (42%) PersAF. The mean procedural and fluoroscopy times were 116 ± 24 and 33 ± 12 min, respectively. Procedure-related complications occurred in four (4.2%) patients.At the 12-month follow-up, after a 3-month blanking period, freedom from recurrences was achieved in 59% [confidence interval (CI): 49–69%] of patients, 62% (CI: 48–75%) in PAF, and 54% (CI: 38–71%) in PersAF group. The difference was not statistically significant at the Kaplan–Meier survival analysis (P = 0.242). Cardioversion to restore sinus rhythm was less frequently needed in PAF group [5% (CI: 1–15%) vs. 25% (CI: 13–41%), P < 0.001]. Redo procedure was performed in 7% (CI: 3–15%) of patients. In the Cox regression analysis, early atrial-tachyarrhythmia recurrence was the only independent predictor of 1-year recurrence (hazard ratio 2.11, CI: 1.06–4.20, P = 0.03).ConclusionThe success rate at 12 months after a single CB-Adv procedure was 62% in patients with PAF and 54% in study participants with PersAF. Early atrial-tachyarrhythmia recurrence appeared to be the only independent predictor of late atrial fibrillation recurrence.

    loading  Loading Related Articles